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It is well known that hormones, vitamins,
pharmaceuticals, and metals can have adverse
effects on bone. Bone effects, mainly congeni-
tal, have also been linked to persistent
organochlorine exposure following a few
notable poisoning incidents. High-level, acci-
dental dietary exposure to hexachlorobenzene
resulted in severe osteoporosis (Cripps et al.
1984; Gocmen et al. 1989), and infants
exposed in utero to high concentrations of
polychlorinated biphenyls (PCBs) and poly-
chlorinated dibenzofurans developed irregular
calciﬁcation of their skull bones (Miller 1985).
Recent epidemiologic studies in popula-
tions with environmental organochlorine
exposure have yielded inconsistent results
regarding whether organochlorine exposure
has an effect on bone properties. Several single-
sex studies have indicated a possible associa-
tion between organochlorine exposure and
bone quality. In 115 Swedish men from the
general population, a significant association
was seen between serum concentrations of the
organochlorines chlorobiphenyl (CB)-28 and
γ-hexachlorocyclohexane and broadband
ultrasound attenuation [an indirect estima-
tion of bone mineral density (BMD)] of the
left os calcis, and between CB-167 and total-
body BMD after adjustment for confounding
variables (Glynn et al. 2000a). In 68 seden-
tary Australian women, a negative correlation
between p,p´-dichlorodiphenyldichloroethylene
(p,p´-DDE) levels and BMD was observed,
suggesting that past exposure to DDT may be
associated with reduced BMD in women
(Beard et al. 2000). Other studies have not
found organochlorine exposure to be associ-
ated with bone effects. In 103 peri- and post-
menopausal women from the United States,
no correlation was found between p,p´-DDE
concentration and bone density or rate of
bone loss at the spine or radius (Bohannon
et al. 2000). In 153 peri- and postmenopausal
Inuit women with high organochlorine expo-
sure from their seafood diet, concentrations
of CB-153 were inversely correlated with
bone parameters in univariate analyses, but,
again, this relationship was no longer evident
after adjustment for potential confounding
variables (Cote et al. 2006).
One study investigated bone effects in
males and females from Sweden. In the initial
study, the risk of hospitalization from fracture
in fishermen and their wives was compared
between those living on the east coast of
Sweden (near the Baltic sea, where environ-
mental organochlorine exposure is likely
attributable to consumption of contaminated
fatty ﬁsh) and those living on the west coast
(Alveblom et al. 2003). There was a signifi-
cantly increased incidence rate ratio for verte-
bral fractures among east coast fisherman’s
wives, with a similar (nonsignificant) ten-
dency in east coast ﬁshermen after adjustment
for age and calendar year, compared with
those dwelling on the west coast. It should be
noted that this exposure assessment is rather
crude and that other fracture types did not
show a similar trend. Following from this
study, the relationship between serum levels
of CB-153 and p,p´-DDE and BMD in a
subset of the Baltic coast ﬁshermen (n = 196)
and their wives (n = 184) was further studied
(Wallin et al. 2005). Univariate analyses
revealed significant negative associations
between CB-153 and BMD in males and
females, but after adjustment for age and
body mass index (BMI), these relationships
did not persist.
Although the epidemiologic evidence is
inconsistent, an increasing number of experi-
mental studies lend biological plausibility to
organochlorine-induced bone effects (Andrews
1989; Badraoui et al. 2007). Animal studies
also have demonstrated that the timing of
exposure can be critical, with effects being
observed at lower dose levels when exposure
occurs during earlier life stages; furthermore,
the same compound seems to have the poten-
tial to modulate bone quality differently
depending on the developmental stage at expo-
sure (Jamsa et al. 2001; Miettinen et al. 2005).
The estrogen status of the exposed individual
has also been shown to inﬂuence the toxicity of
organochlorines on bone. Studies in rats
exposed to the dioxin-like CB-126 showed
that bone strength and composition are
impaired and that estrogen can modulate the
induced effects depending on the estrogen sta-
tus of the individual (Lind et al. 1999, 2000,
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BACKGROUND: Bone toxicity has been linked to organochlorine exposure following a few notable
poisoning incidents, but epidemiologic studies in populations with environmental organochlorine
exposure have yielded inconsistent results.
OBJECTIVES: The aim of this study was to investigate whether organochlorine exposure was associ-
ated with bone mineral density (BMD) in a population 60–81 years of age (154 males, 167 females)
living near the Baltic coast, close to a river contaminated by polychlorinated biphenyls (PCBs).
METHODS: We measured forearm BMD in participants using dual energy X-ray absorptiometry;
and we assessed low BMD using age- and sex-standardized Z-scores. We analyzed blood samples
for five dioxin-like PCBs, the three most abundant non-dioxin-like PCBs, and p,p´-dichloro-
phenyldichloroethylene (p,p´-DDE).
RESULTS: In males, dioxin-like chlorobiphenyl (CB)-118 was negatively associated with BMD; the
odds ratio for low BMD (Z-score less than –1) was 1.06 (95% conﬁdence interval, 1.01–1.12) per
10 pg/mL CB-118. The sum of the three most abundant non-dioxin-like PCBswas positively asso-
ciated with BMD, but not with a decreased risk of low BMD. In females, CB-118 was positively
associated with BMD, but this congener did not inﬂuence the risk of low BMD in women.
CONCLUSIONS: Environmental organochlorine exposures experienced by this population sample
since the 1930s in Sweden may have been sufﬁcient to result in sex-speciﬁc changes in BMD.
KEY WORDS: bone mineral density, p,p´-DDE, polychlorinated biphenyls, toxic equivalents. Environ
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[Online 16 May 2008]2004). CB-126 exposure did not affect bone
mineral density or trabecular bone volume of
tibia in sham-operated rats. In contrast, in
estrogen-deprived ovariectomized rats, CB-126
exposure resulted in a decreased length and
increased bone mineral density of tibia.
Furthermore, estrogen supplementation modu-
lated CB-126-induced effects on bone tissue in
rats (Lind et al. 1999, 2000, 2004). Because of
these various inﬂuences, the effect of exposure
to a number of different organochlorines is
likely to be difficult to predict; nonetheless,
these animal studies suggest a possible causal
relationship between organochlorine exposure
and adverse bone effects. Such a relationship, if
applicable to humans, could play a role in the
observed increase in osteoporosis and osteo-
porotic fractures in the western world (Genant
et al. 1999; Ismail et al. 2002).
The purpose of the present study was to
investigate the relationship between organo-
chlorine exposure and BMD in a subset of the
Osteoporosis Cadmium as Risk Factor
(OSCAR) cohort. The OSCAR cohort was
established to investigate the effect of low-level
cadmium exposure on bone and kidneys
(Alfven et al. 2002, 2004). Because many of
the examined individuals live close to the Baltic
coast, these people might also have experienced
elevated dietary PCB exposure from consum-
ing contaminated fatty ﬁsh. In addition, there
was potential for PCB exposure from a nearby
contaminated river, which was polluted with
PCB containing paper pulp from an upstream
paper mill (Bremle et al. 1998).
Materials and Methods
Full details of the OSCAR study population
can be found elsewhere (Alfven et al. 2002).
In brief, subjects 16–80 years of age who had
resided near a nickel-cadmium battery plant
for at least 5 years between 1910 and 1992
were invited to participate in the OSCAR
study; 904 (62%) agreed to participate. In
addition, workers with previous or current
occupational exposure were invited to partici-
pate, and 117 (48%) agreed to take part. In
total, 1,021 individuals (60%) agreed to par-
ticipate in the study. The OSCAR partici-
pants provided information on employment,
residence, smoking, diet, medical history
(especially regarding kidney diseases and dis-
eases related to osteoporosis). Specially
trained nurses collected urine and blood sam-
ples and measured height and weight.
Forearm BMD was measured with an ambu-
lant instrument (Osteometer DTX-200;
Meditech A/S, Rødovre, Denmark), using
dual energy X-ray absorptiometry, which is
commonly used to evaluate BMD (Alfven
et al. 2000; Glynn et al. 2000a; Wallin et al.
2005). The distal site in the nondominant
forearm was measured with the patient in a
supine position. This site includes both the
radius and the ulna from the 8-mm point (the
point where the radius and ulna are separated
by 8 mm) and 24 mm proximally, and con-
tains 10–20% trabecular bone (Schlenker and
VonSeggen 1976). Internal variation was
checked by daily calibration using a phantom,
and the measurements from the ambulant
instrument were validated against a stationary
hospital-based instrument (Jarup et al. 1998).
In addition to investigating BMD as a
continuous variable, we created a dichoto-
mous variable representing presence or
absence of low BMD for use in logistic regres-
sion analyses. Low BMD was assessed by
computing an age- and sex-standardized
Z-score. A common deﬁnition of low BMD is
Z-score less than –1 (Kanis et al. 1997),
which indicates 1 standard deviation below a
sex- and age-standardized mean obtained
from a reference population provided by the
instrument supplier.
Blood samples from a subset of the
OSCAR cohort consisting of participants ≥ 60
years of age (n = 325) were included in this
study [insufficient sample remained and/or
labeling was unclear in 23 out of 348 samples
(6.6%), meaning that we could assess only
325 out of 348 eligible participants]. Samples
were analyzed for five mono-ortho chlorine
substituted congeners (CBs 105, 118, 156,
157, and 167), expressed in terms of toxic
equivalency (TEQmono-ortho), and individual
CB-118 levels, to assess the effect of the
dioxin-like activity. The sum of three most
abundant non-dioxin-like (or di-ortho chlorine
substituted) CBs 138, 153, and 180 (Σ3PCB),
and individual CB-153 levels were also ana-
lyzed. We measured CB-153 because the con-
centration of this congener correlates well with
total and dioxin-like PCB concentrations in
plasma and serum (Glynn et al. 2000b). Σ3PCB
is considered to be an indicator of the content
of total PCBs in human samples; this measure
represented, on average, 61% of the human
PCB body burden (European Food Safety
Authority 2005). Finally, we also analyzed
p,p´-DDE, the persistent metabolite of DDT
(dichlorodiphenyltrichloroethane) because this
organochlorine has been measured in other
studies exploring the effects of organochlorines
on BMD (Beard et al. 2000; Glynn et al.
2000a; Wallin et al. 2005). Ethical approval
for this study was obtained from the
Karolinska Institutet ethics committee, and all
participants gave their written, informed con-
sent before the OSCAR study.
The analytical method for the measure-
ment of PCBs was initially developed in serum
(Mariani et al. 2002; Turci et al. 2004), but
has been extended to plasma and whole blood.
Before the analysis of the OSCAR samples for
this study, analyses of PCBs in whole blood,
serum, and plasma derived from the same
blood sample were performed, and results
showed no major differences between these
matrices in the distribution of the congeners,
and the coefficients were close to 1 [see
Supplemental Material, Figure 1 (online at
http://www.ehponline.org/members/2008/
11107/suppl.pdf)]. Analysis of whole blood,
however, has been suggested to better reﬂect
the PCB body burden (Janak et al. 1999).
Briefly, after thawing, aliquots of 0.5 mL of
blood samples were spiked with a mixture of
the eight PCB congeners (13C12 labeled;
Wellington Laboratories, Guelph, Ontario,
Canada) and p,p´-DDE. Sulfuric acid was
added to a final volume of 2.5 mL. After
cleanup overnight on an Extrelut column
(Merck, Darmstadt, Germany), samples were
concentrated to a small volume and analyzed
by high-resolution gas chromatography
(CG)–high resolution mass spectrometry using
a trace CG (Finnigan, Bremen, Germany) pro-
vided with a GC PAL autosampler (CTC-
Analytics, Zwingen, Switzerland) coupled to a
Thermoﬁnnigan MAT95XP mass spectrome-
ter. The mass spectrometer was operated in
electron ionization mode, using selected ion
monitoring at a mass resolution of 10,000.
Quantiﬁcation was done by the isotopic dilu-
tion method. We carried out blank analyses
routinely for every 20 samples, and for the def-
inition of the limit of detection (LOD), a sig-
nal-to-noise ratio of 3:1 was chosen. For the
TEQmono-orthocalculation the latest toxic equiv-
alency factors (TEFs) were used (Van den Berg
et al. 2006) and when the CB concentration
values were below the LOD, they were entered
as 0 (lower bound method).
We evaluated associations between
organochlorine levels and BMD in SPSS 12.0
for Windows (SPSS Inc., Chicago, IL, USA)
using univariate and multivariate linear regres-
sion and logistic regression analyses. Given the
probable hormonal action of organochlorines
on bone, and given the very large difference in
osteoporosis incidence in males and females
after 60 years of age, it seemed most appropri-
ate to assess the relationships between organo-
chlorines and BMD measures in males and
females separately. Information on potentially
confounding lifestyle factors and food con-
sumption habits collected for the OSCAR
cohort were included in the linear regression
model if they fulfilled the stepwise criteria
(probability-of-F-to-enter ≤ 0.10, probability-
of-F-to-remove ≥ 0.15) to aid the interpretation
of the results. Because the OSCAR cohort was
originally set up to explore the effect of cad-
mium on BMD, blood cadmium was included
as a potential confounding variable in the linear
and logistic regression analyses presented.
Results
The blood concentration levels ranged from
0.002 to 0.067 pg TEQmono-ortho/mL for the
dioxin-like PCBs, from 438 to 8,960 pg/mL
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p,p´-DDE (Table 1). Women had signifi-
cantly higher levels of CB-118 and p,p´-DDE
than did men.
In unadjusted analyses, signiﬁcant negative
correlations were seen between CB-118 and
BMD (Pearson correlation coefficient =
–0.130; p = 0.020) when males and females
were investigated as one group. When males
and females were investigated separately, none
of the individual CB congeners was signifi-
cantly correlated with BMD. There were sig-
niﬁcant positive correlations between each of
the five organochlorine markers of interest.
The dioxin-like organochlorines CBs 105,
118, 156, and 167 were all strongly correlated
with TEQmono-ortho in males, females, and the
whole group (Pearson correlation coefficient
> 0.6); CB-157 showed far weaker, even non-
signiﬁcant correlations with the other organo-
chlorines. CB-118 showed consistently strong
correlations with the TEQmono-ortho measure
(correlation coefficient > 0.9) and with the
Σ3PCB measure (correlation coefﬁcient > 0.6).
The abundant non-dioxin-like congeners were
always strongly correlated with each other
(correlation coefficient > 0.6), and CB-153
was always very strongly correlated with the
Σ3PCB measure (correlation coefﬁcient > 0.9).
In males, p,p´-DDE showed relatively strong
correlations with TEQmono-ortho, CB-118,
Σ3PCB, and CB153 (correlation coefficient
~ 0.5), though these correlations were weaker
in women (correlation ~ 0.4).
As anticipated, in bivariate analyses, age
was negatively correlated with BMD, and
BMI was positively correlated with BMD
(data not shown). In males, alcohol was nega-
tively correlated and milk consumption was
positively correlated with BMD. In females,
age at menopause and number of reproduc-
tive years (age at menopause minus age at
menstruation) were both positively correlated
with BMD; age at menstruation was nega-
tively correlated with BMD. Contraceptive
pill use was associated with an increased
BMD, as was ever having been pregnant.
Table 2 shows the results from multivariate
linear regression analysis in males and females.
In males, multivariate linear regression analysis
indicated that age, BMI, blood cadmium, and
milk consumption explained 25% of the vari-
ability in BMD; none of the organochlorines
was signiﬁcantly associated with BMD when
entered into the model individually. The
organochlorine variables were then entered
stepwise into the model, sequentially, in order
of the smallest probability of F (if F ≤ 0.10),
until no more variables were eligible for inclu-
sion or removal (F ≥ 0.15). In this model
CB-118 was negatively associated (B =
–0.00024; p = 0.002) and Σ3PCB positively
associated (B = 0.00002; p = 0.003) with BMD
in males, explaining an additional 6% of the
variability in BMD. In females, multivariate lin-
ear regression analysis indicated that age, BMI,
blood cadmium, age at menstruation, and ever
having being pregnant explained 39.5% of the
variability in BMD. When organochlorines
were entered individually into this model,
CB-118 was signiﬁcantly positively associated
with BMD (B = 0.00008; p = 0.045), explain-
ing a further 2% of the variability in BMD. No
additional organochlorines contributed signiﬁ-
cantly to the model after stepwise entry.
Variables representing interactions between the
organochlorines and cadmium did not explain
any further variability in BMD.
A dichotomous variable representing pres-
ence or absence of low BMD (defined as
Z-score less than –1) was used in logistic
regression analyses; 47 of 154 (30.5%) of the
males, and 31 of 167 (18.6%) of the females
had low BMD. Those organochlorines that
were found to signiﬁcantly explain variability
in BMD after stepwise entry into the multi-
variate linear regression models (CB-118 and
Σ3PCB in males and CB-118 in females) were
included in the multivariate logistic regression
as categorical variables (tertiles). Where a linear
dose–response relationship seemed apparent by
tertiles, these variables were reentered into the
Hodgson et al.
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Table 2. Multivariate linear regression analyses showing associations between BMD (g/cm2) and explana-
tory variables. 
Malesa Femalesb
Variable Coefﬁcient (B) SE p-Value Coefﬁcient (B) SE p-Value
Age –0.004009 0.001123 < 0.001 –0.005635 0.000953 < 0.001
BMI 0.008255 0.002006 < 0.001 0.006300 0.001209 < 0.001
ln blood-Cd (nmol/L) –0.013383 0.005946 0.026 –0.010184 0.008257 0.220
Milk (dL/week) 0.000544 0.000245 0.028 — — —
Age at menstruation  — — — –0.009020 0.003598 0.013
Ever pregnant — — — 0.037579 0.015894 0.020
CB-118 –0.000110 0.000062 0.079 0.000080 0.000039 0.045
TEQmono-ortho –0.225387 1.156013 0.846 1.652927 0.861054 0.057
CB-153 0.000011 0.000011 0.331 0.000009 0.000010 0.385
Σ3PCB 0.000008 0.000006 0.154 0.000007 0.000006 0.223
p,p´-DDE –0.000003 0.000003 0.323 0.000003 0.000002 0.184
Age, BMI, blood cadmium, and milk (males) or age at menstruation and ever pregnant (females) entered simultaneously;
organochlorines then entered individually into the model. 
aAdjusted for age, BMI, blood-cadmium, and milk consumption (ﬁnal sample size = 150). bAdjusted for age, BMI, blood-
cadmium, age at menstruation, and ever pregnant (ﬁnal sample size = 134).
Table 1. Characteristics of study participants, including mean, minimum, and maximum blood levels of
measured organochlorines, and percent of samples below the LOD.
Males (n = 154) Females (n = 167)
Continuous variables Mean  Range Mean  Range
Age 70.8 60–81 69.9 60–81
BMI 26.2 18.1–34.5 27.0 17.5–46.3
Blood cadmium (nmol/L) 10.4*  1.0–84.6 5.4* 1.0–45.9
Alcohol (g/week) 10.1*  0–181 2.9*  0–44
Milk (dL/week) 36.1* 0–140 26.7*  0–70
Age at menstruation (n = 135) — — 13.9 10–18
Age at menopause(n = 146) — — 48.8 30–85
Reproductive years(n = 123) — — 35.1 15–75
BMD (g/cm2) 0.51* 0.27–0.71 0.38*  0.13–0.64
Dichotomous variables Yes (%)  No (%) Yes (%)  No (%)
Low BMD (Z-score less than –1) 47 (30.5) 107 (69.5) 31 (18.6) 136 (81.4)
Cortisone (> 3 months) 18 (12) 132 (88) 16 (9.6) 150 (90.4)
Ever pregnant — — 142 (85.5) 24 (14.5)
Contraceptive pill use(n = 156) — — 26 (16.7) 130 (86.3)
Organochlorines (pg/mL) LOD % < LOD Mean  Range Mean  Range
CB-105 4 7.5 42.1 < LOD–421 49.0 < LOD–366
CB-118 5 0.3 184* < LOD–1,359 236* < LOD–1,145
CB-156 8 2.8 116* < LOD–450 98.5* < LOD–243
CB-157 3 26 20.0 < LOD–211 16.4 < LOD–64.4
CB-167 2 12 31.6 < LOD–172 34.3 < LOD–127
TEQmono-ortho — — 0.012 0.002–0.067 0.0130 0.003–0.053
CB-138 6 0.0 561 34.0–2,239 582 121–1,461
CB-153 6 0.0 1,290 196–4,360 1,260 328–4,587
CB-180 13.5 0.3 819* 117–3,309 706*  < LOD–1,966
Σ3PCB — — 2,670 438–8,957 2,548 717–7,010
p,p´-DDE 8 0.0 2,405* 16–14,268 3,126*  259–17,519
*Signiﬁcant difference between males and females (p < 0.05).model as continuous variables to maximize
power in assessing the dose–response relation-
ship. Table 3 shows the results from logistic
regression analysis in males and females. In
males, the odds ratio (OR) for low BMD
decreased with increasing BMI and milk con-
sumption and increased with increasing blood
cadmium levels. The risk of low BMD
increased by tertile of CB-118, and when ana-
lyzed as a continuous variable, the OR was
1.06 (95% conﬁdence interval 1.01–1.12) for
every 10 pg/mL CB-118. The risk of low
BMD did not show a clear trend across tertiles
of Σ3PCB. In women, the ORs for low BMD
decreased with increasing BMI and increased
with increasing age at menstruation; however,
the risk of low BMD did not show a consistent
trend with tertiles of CB-118. 
Discussion
The present study is one of the largest to date
to assess the relationship between organochlo-
rine levels in blood and BMD in an environ-
mentally exposed population. The ﬁndings of
this study suggest that even at relatively low
levels of organochlorine exposure, BMD
might be affected, at least in males, after con-
trolling for major confounding variables.
Despite the large variability of the individual
values, spanning over three orders of magni-
tude, the blood concentration levels of these
pollutants in this population are in the range
of the values detected in human serum and/or
blood samples for the general population
(Botella et al. 2004; Turci et al. 2004;
Wilhelm et al. 2003). Nonetheless, there was a
signiﬁcant positive dose–response relationship
in men between the dioxin-like congener
CB-118 and BMD (OR = 1.06 per 10 pg/mL;
95% confidence interval 1.01–1.12). In
females, after finding a small but significant
positive association between CB-118 and
BMD in the linear regression analysis, we
anticipated a decrease in risk of low BMD
with increasing levels of CB-118; however, the
risk of low BMD did not show a consistent
trend with tertile of CB-118. This contradic-
tory finding, in conjunction with the small
change in proportion of BMD variability
explained by this variable in the linear regres-
sion suggests that CB-118 is unlikely to exert
an important inﬂuence on BMD in females in
this population sample.
In this study, women had significantly
higher levels of CB congener 118 and
p,p´-DDE than did men. Consistently higher
levels of CB-118 in women were also reported
in Native Americans in the United States
(Schaeffer et al. 2006), but higher levels of
p,p´-DDE in women have not been reported
elsewhere. In fact, other studies have reported
no difference in p,p´-DDE levels by sex
(Sandanger et al. 2006) or reported higher
p,p´-DDE levels in males than in females
(Bjerregaard et al. 2001; Jonsson et al. 2005).
Lower levels of p,p´-DDE in younger females
are likely attributable to breast-feeding (which
may reduce plasma levels of persistent organic
pollutants) and lower dietary exposure; as
such, this sex difference is likely to be less evi-
dent in populations > 40 years of age, by
which age the sex imbalance in organochlo-
rine accumulation due to breast-feeding will
be reduced (Sandanger et al. 2003).
These sex differences in organochlorine
levels are unlikely to be explained by age,
which was similar for the males and females
in this study. The main source of exposure to
organochlorines for this population is antici-
pated to be dietary, mainly via fish, to some
extent caused by intake of salmon from the
Emån river (a well-known salmon-fishing
river), which has been polluted with PCBs
from an upstream paper mill. More impor-
tant, the local population may be exposed to
PCBs by eating fish from the nearby Baltic
Sea. Farmed salmon and wild herring in the
Baltic Sea are known to have high concentra-
tions of PCBs. Although individual-level data
on fish consumption were not available for
analysis, it has been reported by the Swedish
National Food Administration that older
women eat more ﬁsh than older men (Becker
et al. 2007). The difference observed in levels
of organochlorines in this study could there-
fore be attributable to a combination of fac-
tors including sex-specific differences in
consumption patterns, differential metabo-
lism (Landi et al. 1998), or elimination by
lactation (Sandanger et al. 2003), although
these mechanisms have not been shown to be
speciﬁc to CB-118 or to p,p´-DDE.
No other epidemiologic studies have
reported similar sex differences with respect to
BMD to those found in this study, although
most studies on this topic have focussed on
single-sex populations. Similarly the literature
on organochlorine exposure and sex-specific
effects on BMD in experimental animals is
very limited (van der Ven et al. 2006),
although sex differences with respect to other
outcomes have been observed, possibly indi-
cating a greater sensitivity of males to repro-
ductive system and neurobehavorial effects
(Gray et al. 1997a, 1997b). Whether the
likely hormonal action of organochlorines
could explain or contribute to the different
effects on BMD seen in males and females in
this study is not clear.
The findings from this study suggest an
effect of organochlorine exposure on BMD at
levels of exposure experienced in a population
in southern Sweden, but there are several limi-
tations of the study that need to be considered.
Although this is one of the largest studies to
date, when males and females were split into
separate groups for analysis, the power of the
study to detect statistically signiﬁcant relation-
ships between organochlorine exposure and
BMD was limited. In this study we had data on
blood levels of organochlorines in adults, but
we do not know about early life exposures,
which may be more important than adult expo-
sures in determining the effects of organochlo-
rines on bone. Although it was possible to
control for several potentially confounding vari-
ables, the linear regression analyses indicate that
more than half the variability in BMD is likely
to be explained by other, unknown variables
that could not be taken into account in this
study. Further work should be directed toward
establishing whether the sex-specific effects
observed in this study are also evident in other
environmentally exposed populations. More
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Table 3. Logistic regression model for low BMD (Z-score less than –1) in males and females. 
Variable OR (95% CI) p-Value
Males (n = 150)a
BMI 0.83 (0.72–0.95) 0.009
ln Blood cadmium (nmol/L) 1.76 (1.19–2.59) 0.004
Milk consumption (dL/week) 0.97 (0.95–0.99) 0.004
CB-118 (< 33rd percentile) 1.00 (referent) —
CB-118 (33rd–67th percentile) 1.48 (0.55–3.97) 0.437
CB-118 (> 67th percentile) 2.11 (0.63–7.12) 0.227
CB-118 (continuous variable) 1.06 (1.01–1.12) 0.027
Σ3PCB (< 33rd percentile) 1.00 (referent) —
Σ3PCB (33rd–67th percentile) 1.17 (0.44–3.16) 0.753
Σ3PCB (> 67th percentile) 0.91 (0.27–3.02) 0.879
Σ3PCB (continuous variable) 1.00 (0.99–1.00) 0.101
Females (n = 134)a
BMI 0.80 (0.70–0.93) 0.003
ln Blood cadmium (nmol/L) 0.88 (0.40–1.92) 0.745
Age at menstruation 1.48 (1.07–2.03) 0.016
Ever pregnant 0.47 (0.13–1.70) 0.251
CB-118 (< 33rd percentile) 1.00 (referent) —
CB-118 (33rd–67th percentile) 2.29 (0.66–7.92) 0.191
CB-118 (> 67th percentile) 2.13 (0.58–7.84) 0.255
CI, conﬁdence interval. In males, BMI, blood cadmium, milk, CB-118 (tertiles) and Σ3PCB (tertiles) were entered simultane-
ously; tertiles of CB-118 and Σ3PCB were then replaced with the continuous variables, also entered simultaneously. In
females, BMI, blood cadmium, age at menstruation, ever pregnant, and CB-118 (tertiles) were entered simultaneously.
aFinal sample size.Hodgson et al.
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detailed lifestyle data could be used to elucidate
whether any sex-speciﬁc effects are caused by a
hormonal action of the organochlorines (or the
hormonal status of the individuals at the time
of exposure), or whether these observations are
due to other sex-speciﬁc differences related to
lifestyle, diet, or occupation.
The purpose of this study was to investi-
gate the relationship between environmental
organochlorine exposure and BMD in a popu-
lation potentially exposed to PCBs from the
environment to add to the sparse and incon-
sistent literature on this important topic. The
findings of this study indicate that exposure
to some CB congeners, even at relatively low
levels, may influence BMD and that this
effect may be sex speciﬁc.
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